Palvella Therapeutics PVLA
NASDAQ PVLA
$132.73 -5.20 (-3.77%)
At close: Oct 1, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Long-Term Deferred Tax (2013 - 2015)

Updated

Palvella Therapeutics' Long-Term Deferred Tax came in at $24,464 for Q3 2015, up 0.1% from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Long-Term Deferred Tax (2013 - 2015) Analysis & Trends

At the end of FY2014, Palvella Therapeutics' Long-Term Deferred Tax was $26,522, up 40.5% from FY2013.

  • Going back by year, Long-Term Deferred Tax was $18,877 in FY2013.
  • The five-year range for quarterly Long-Term Deferred Tax is $18,877 (Q4 2013) to $26,522 (Q4 2014).
  • Business Quant data shows PVLA's Long-Term Deferred Tax at $24,446 (Q2 2015), $23,541 (Q1 2015) and $26,522 (Q4 2014) in the three quarters before Q3 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Palvella Therapeutics 1.99 Bn 1.73 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 24,464.00
Jun 30, 2015 24,446.00
Mar 31, 2015 23,541.00
Dec 31, 2014 26,522.00
Dec 31, 2013 18,877.00
API Access

Palvella Therapeutics Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=PVLA&period=max&api_key=YOUR_API_KEY